In a recent opinion piece, Vikas Patel notes a significant trend where patients are opting for peptide therapies rather than traditional statins, despite the established evidence supporting statins.
This shift raises important questions about the relationship between the volume of clinical evidence and public trust in medical treatments.
The implications for healthcare systems are profound, as patient choices may influence treatment protocols and the adoption of new therapies.